- 01Animal lifespan results did not carry over to people
Resveratrol's reputation comes from yeast, worms, flies and mice, and from lab dishes using concentrations a capsule cannot reach: the body converts nearly all of it as it is absorbed. In people, the evidence is a handful of small trials with mixed results, the best of them on bone in postmenopausal women, plus a signal that it may blunt the benefits of exercise.
Resveratrol is a compound some plants make to fend off fungus and stress, found in grape skins, red wine, peanuts, berries and the root of Japanese knotweed. It became famous after lab work linked it to longer life in yeast, worms and flies, and supplements now sell it for healthy aging. In people, the story is smaller and more mixed: no trial has tested whether it helps anyone live longer, the gut and liver convert nearly all of it as it is absorbed 1, and the human trials that exist are small, short and often contradict each other.
What is resveratrol?
Resveratrol is a plant compound, and the form studied in trials is trans-resveratrol. For the basics, what it is and what it does in your body has its own page, and this guide covers the evidence, aging, menopause, blood sugar, exercise, how much studies use, when and how to take it, forms, side effects and interactions.
It also behaves as a phytoestrogen, a plant compound that can act on the body's estrogen receptors 12. That is one reason trials have focused on postmenopausal women, and one reason people with hormone-sensitive conditions should ask before taking it.
Why so little reaches your blood
In a study using labeled resveratrol, at least 70% of a 25 mg oral dose was absorbed, yet only trace amounts of unchanged resveratrol (under 5 ng/mL) showed up in the blood. The gut and liver rapidly attach sulfate and glucuronic acid groups to it, and those converted forms are what circulates 1. At much larger amounts of 0.5 to 5 g a day, the converted forms in blood exceeded unchanged resveratrol by up to 20-fold 2. This matters because most of the exciting lab results used unchanged resveratrol at concentrations a capsule does not deliver. Whether the converted forms do anything useful is still being worked out.
What resveratrol is good for: the evidence, graded
Strong means several good randomized trials or a meta-analysis (a study that pools many trials) agree. Moderate means several randomized trials, mostly positive but small or short. Limited means few or small trials, or mixed results. Early means lab, animal or one pilot study only. Not supported means good trials found no benefit. Our guide to how supplements are judged explains why a change in a lab marker is weaker evidence than a change in how people feel or fare.
| Use | What the research found | Evidence | Source |
|---|---|---|---|
| Healthy aging and longer life | Lifespan effects are from yeast, worms, flies and mice; in 783 older adults, dietary resveratrol was not linked to death rates over 9 years | Early | 4 |
| Bone density after menopause | 75 mg twice a day for 12 months: small gains in spine and hip bone density and a 7.24% fall in CTX, a bone-breakdown marker | Limited | 1211 |
| Everyday pain and well-being after menopause | Lower pain scores in a 24-month crossover trial; a pooled analysis of 10 trials agreed on pain | Limited | 1011 |
| Thinking and memory after menopause | One 2-year trial found better overall cognitive scores; the pooled analysis found no clear effect | Limited | 911 |
| Blood sugar in type 2 diabetes | 9 small trials, 283 people: fasting glucose fell 0.29 mmol/L and fasting insulin fell; HbA1c barely changed | Limited | 5 |
| Metabolism in healthy, non-obese women | 75 mg a day for 12 weeks: no change in insulin sensitivity, body fat, lipids or inflammation | Not supported | 6 |
| Metabolism in obese men | 11 men, 30 days at 150 mg: lower blood pressure, liver fat and glucose | Early | 7 |
| Fitness gains from exercise | A trial of 250 mg a day: it blunted the improvement in fitness, blood pressure and cholesterol from 8 weeks of training in older men | Not supported | 3 |
| Walking with narrowed leg arteries | Adding 125 mg to NR gave no extra benefit over NR alone | Not supported | 15 |
| Skin, taken by mouth | We found no good randomized trials of oral resveratrol for skin aging | Early | None found |
Does resveratrol slow aging?
No one has shown that in people. The idea came from lab work suggesting resveratrol activates sirtuins, proteins tied to the cell's response to calorie restriction, and from animal lifespan studies. In people, the closest test is observational: the InCHIANTI study measured resveratrol by-products in the urine of 783 adults aged 65 and over in two Tuscan villages and followed them for 9 years. Deaths ran at 34.4%, 31.6%, 33.5% and 37.4% from the lowest to the highest quarter of resveratrol, with no meaningful trend 4.
Resveratrol levels achieved with a Western diet did not have a substantial influence on health status and mortality risk of the population in this study.Semba and colleagues, InCHIANTI study, JAMA Internal Medicine, 2014 4
Diet supplies far less than a capsule, so this does not rule out an effect from supplements. It does mean the red-wine-and-longevity story has no support from the people who drink the most red wine. A trial in healthy, non-obese postmenopausal women also found that 12 weeks of 75 mg a day did not switch on the sirtuin pathway in muscle or fat at all 6. If longevity is the goal, our guide to nicotinamide riboside covers the other half of the sirtuin pitch, with the same honest gaps.
Resveratrol benefits for women after menopause
The most consistent human data come from the RESHAW trial (Resveratrol for Healthy Aging in Women), which gave 125 postmenopausal women aged 45 to 85 either 75 mg of trans-resveratrol twice a day or a placebo for 12 months, then switched them for another 12 months.
Bone
After 12 months on resveratrol compared with placebo, bone density rose by 0.016 g/cm2 in the lumbar spine and 0.005 g/cm2 at the femoral neck (top of the thigh bone), and CTX, a blood marker of bone breakdown, fell 7.24% 12. A 2025 pooled analysis of 10 trials in postmenopausal women also found lower CTX, but no change in the bone-building markers ALP and osteocalcin 11. These are small changes from essentially one trial. Osteoporosis is diagnosed with a bone density scan and treated by a clinician, and resveratrol is not a replacement for that care. Our guide to bone markers explains what CTX measures.
Pain, mood and thinking
In the same trial, resveratrol reduced overall pain scores, eased the physical symptoms of menopause a little and improved general well-being 10, and overall cognitive performance scored better on resveratrol, an effect the authors described as a 33% improvement but which was small in statistical terms (Cohen's d of 0.17) 9. When the 2025 meta-analysis pooled every trial, the pain benefit held, but there was no significant effect on cognition, mood, menopausal symptoms, sleep, blood pressure, or blood sugar and cholesterol 11. That makes pain Limited and thinking Limited at best.
Blood sugar and metabolism
A meta-analysis of 9 randomized trials with 283 people with type 2 diabetes found resveratrol lowered fasting glucose by 0.29 mmol/L (about 5 mg/dL), lowered fasting insulin and the HOMA-IR insulin-resistance score, and lowered blood pressure, while HbA1c and cholesterol barely changed. Trials using 100 mg a day or more showed a larger glucose effect 5. These were small trials of people already on diabetes care. Resveratrol is not a treatment for diabetes, which is diagnosed and treated by a clinician, and it is never a swap for a prescribed medicine.
In people without diabetes the results split. Eleven obese men who took 150 mg a day for 30 days had lower blood pressure, glucose, liver fat and ALT (a liver enzyme) than on placebo 7. But 12 weeks of 75 mg a day in non-obese women with normal blood sugar changed nothing: not insulin sensitivity, body composition, lipids nor inflammation 6. If you want to see where your own numbers sit, the HOMA-IR calculator and our blood sugar guide are a better starting point than any supplement; prediabetes is a diagnosis to work through with a clinician.
Can resveratrol interfere with exercise?
It might. In a 2013 trial, 27 inactive men around 65 years old did 8 weeks of high-intensity training while taking either 250 mg of trans-resveratrol a day or placebo. The placebo group's maximal oxygen uptake (a measure of aerobic fitness) improved 45% more than the resveratrol group's, only the placebo group saw blood pressure fall, and resveratrol cancelled training's improvements in LDL cholesterol, the cholesterol ratio and triglycerides 3. That 250 mg is the same amount of trans-resveratrol as one LifeFrom capsule. One small trial does not settle it, but anyone training for fitness has a reason to think twice. The VO2 max calculator estimates the fitness measure the trial tracked.
How much resveratrol do studies use?
These are the amounts trials used, as research history rather than a dose for you. There is no Recommended Dietary Allowance for resveratrol and no official upper limit.
| Use studied | Amount per day | Form | Length | Source |
|---|---|---|---|---|
| Metabolism, non-obese women | 75 mg | Trans-resveratrol | 12 weeks | 6 |
| Bone, pain, cognition after menopause | 150 mg (75 mg twice a day) | Trans-resveratrol | 12 months per arm | 129 |
| Metabolism, obese men | 150 mg | Resveratrol (resVida) | 30 days | 7 |
| Exercise training, older men | 250 mg | Trans-resveratrol | 8 weeks | 3 |
| Walking in PAD, added to NR | 125 mg | 98% pure trans-resveratrol | 6 months | 15 |
| Drug-clearing enzymes, healthy adults | 1 g | Resveratrol | 4 weeks | 8 |
| Safety and IGF-1, healthy adults | 0.5, 1, 2.5 or 5 g | Resveratrol | 29 days | 2 |
| Multiple myeloma (drug trial) | 5 g | SRT501, a micronized drug formulation | About 4 months; stopped for kidney failure | 14 |
Harm tracked dose: 2.5 and 5 g a day caused mild to moderate stomach and bowel symptoms in healthy volunteers 2, and 5 g a day of a micronized drug form caused serious adverse events, mainly kidney failure, in people with multiple myeloma 14. One LifeFrom capsule holds 250 mg of trans-resveratrol, more than the 150 mg a day used in the bone trial and the same as the exercise trial, and far below the amounts tied to harm.
When and how to take resveratrol
How resveratrol was taken in trials
How long does resveratrol take to work? It will not feel like anything. Trials that found a change ran from 30 days for metabolic markers 7 to 12 months for bone density 12. What is the half-life of resveratrol? Only trace amounts of unchanged resveratrol reach the blood, while its converted forms had a combined half-life of about 9 hours in one study 1, so it does not build up much from day to day.
Forms of resveratrol
| Form | What it is | What to know |
|---|---|---|
| Trans-resveratrol | The form used in nearly all human trials | Labels should state how much trans-resveratrol a serving holds |
| Japanese knotweed extract | A root extract standardized to a share of trans-resveratrol (often 50%) | 500 mg of a 50% extract yields 250 mg of trans-resveratrol |
| Micronized resveratrol (SRT501) | A drug formulation of very fine particles, built for higher blood levels | A myeloma trial of 5 g a day was stopped for kidney failure 14 |
| Red wine and grapes | Food sources with small amounts | Diet-level intake was not tied to longer life 4; alcohol carries its own risks |
Resveratrol side effects
At the amounts in most supplements, trials have reported few problems. In the 29-day study of 40 healthy volunteers, resveratrol was described as safe, but 2.5 and 5 g a day caused mild to moderate gastrointestinal symptoms 2. In the PAD trial, diarrhea was reported by 54.6% of people taking NR plus 125 mg of resveratrol, against 39.3% on NR alone and 27.6% on placebo 15.
| Usually mild | Needs prompt care |
|---|---|
| Loose stools or diarrhea, more likely at gram doses | On a blood thinner: unusual bruising, bleeding gums, nosebleeds that will not stop, black stools or blood in urine. Stop the supplement and get same-day care. |
| Nausea, bloating or stomach cramps | Passing much less urine, swelling of the legs or new confusion, especially with myeloma or kidney disease: same-day care |
| Headache | Hives with swelling of the face or lips, or trouble breathing: emergency care |
| Lightheadedness when standing, more likely on blood pressure medicines | On diabetes medicines: shakiness, sweating, confusion or a pounding heartbeat can be low blood sugar and needs prompt care; fainting needs same-day care |
Who should avoid resveratrol or ask first
- Pregnancy and breastfeeding: we found no trials of resveratrol supplements in pregnant or breastfeeding women, so safety is unknown. Ask your obstetric clinician first.
- Children: trials enrolled adults, and the label says to keep it out of reach of children.
- Blood thinners or a bleeding disorder: in rats, resveratrol raised warfarin levels and INR 13, and in people it slowed CYP2C9, an enzyme that clears warfarin 8. Ask first, and tell your care team before surgery.
- Kidney disease or multiple myeloma: the 5 g myeloma trial was stopped after kidney failure 14. That was 20 times a 250 mg capsule, but it is a reason to ask your specialist first.
- Hormone-sensitive conditions, including breast, uterine or ovarian cancer and endometriosis: resveratrol can act as a phytoestrogen 12, so ask your oncologist or gynecologist first.
- Cancer treatment: ask your oncology team before adding any supplement.
- Liver disease: ask the clinician who manages it, since high doses change liver enzyme activity 8.
Resveratrol interactions
The best human data come from a 2010 study in 42 healthy volunteers who took 1 g a day for 4 weeks. Resveratrol inhibited three enzymes in the CYP450 family (the liver's main drug-clearing system), CYP3A4, CYP2D6 and CYP2C9, and sped up a fourth, CYP1A2. The authors warned this 'could potentially lead to increased adverse drug reactions or altered drug efficacy' 8. Nobody has tested whether 250 mg does the same.
| Medicine | What can happen | Why | What to do |
|---|---|---|---|
| Warfarin and other blood thinners | Higher warfarin levels and INR; more bleeding risk | Inhibits CYP2C9 in people at 1 g 8; raised warfarin exposure and INR in rats 13 | Talk to the clinician who manages your warfarin before starting; INR may need checking |
| Antiplatelet drugs such as aspirin or clopidogrel | Possible added bleeding tendency | Shared clotting effects suspected; human data are thin | Ask your prescriber or pharmacist |
| Drugs cleared by CYP3A4, CYP2D6 or CYP2C9 (many statins, some blood pressure drugs, antidepressants, sedatives) | Higher drug levels and more side effects | Enzyme inhibition in a trial at 1 g a day 8 | Ask your pharmacist to check your list |
| Diabetes medicines | Extra glucose lowering | Fasting glucose fell in type 2 diabetes trials 5 | Tell your prescriber, who may want closer glucose checks |
| Blood pressure medicines | A small extra drop in blood pressure | Systolic and diastolic pressure fell in diabetes trials 5 | Ask your prescriber; note dizziness on standing |
| Hormone therapy, tamoxifen or aromatase inhibitors | Unclear; could work for or against the drug | Acts as a phytoestrogen 12 | Ask your oncologist or prescriber first |
| Caffeine and drugs cleared by CYP1A2 | Faster clearance at high amounts | CYP1A2 was induced in a trial at 1 g a day 8 | Usually minor; mention it to your pharmacist |
| Bortezomib and other myeloma treatment | Kidney failure at 5 g in a drug trial | Seen with SRT501 plus bortezomib in myeloma 14 | Avoid unless your hematologist agrees |
Supplements to pair or keep apart
| Supplement | Together or apart | Why |
|---|---|---|
| Berberine | Ask first if you take diabetes medicines or drugs with narrow dosing | Both lower blood sugar and both affect drug-clearing enzymes; they share LifeFrom's Microbiome pack |
| Alpha lipoic acid | Ask first if you take diabetes medicines | Two blood-sugar lowerers together; they share the Antioxidants pack |
| Turmeric | Ask first if you take a blood thinner | Both are suspected of a mild effect on clotting; they share the Microbiome pack |
| Quercetin | Together is common | Another polyphenol in both packs; also inhibits some drug-clearing enzymes, so mention both to your pharmacist |
| Nicotinamide riboside | Together is fine; no added benefit shown | Sold as a sirtuin pairing, but adding resveratrol to NR gave no extra walking benefit and more diarrhea 15 |
| NAC and vitamin C | Together is fine | Pack-mates in Antioxidants; no known interaction |
Blood tests worth knowing about
No routine blood test measures resveratrol. The markers below are the ones trials saw move, or the safety checks that matter if you also take certain medicines. Ask your clinician whether any of them are worth checking for you.
| Marker | Why it matters with resveratrol | When it is usually checked |
|---|---|---|
| INR | The warfarin safety number; resveratrol raised it in rats and slows warfarin's clearing enzyme in people 138 | Regularly if you take warfarin, and after any change in supplements |
| Fasting glucose and fasting insulin | Both fell in type 2 diabetes trials 5 | Blood sugar screening or diabetes care |
| CTX | Bone breakdown fell 7.24% in the 12-month trial 12 | Sometimes during osteoporosis care |
| LDL cholesterol | Resveratrol cancelled the LDL improvement from training in older men 3 | Routine lipid panel |
| ALT | A liver check; ALT fell in obese men over 30 days 7 | Routine metabolic panel |
| Creatinine and eGFR | Kidney checks, given the kidney failure seen at 5 g in myeloma 14 | Routine metabolic panel; more often with kidney disease |
Our guides to clotting tests and kidney function explain INR and eGFR, and the eGFR calculator turns a creatinine result into a kidney filtration estimate. A result outside the range on any of these is a conversation for your clinician, not a reason to start or stop a supplement on your own.
Resveratrol in the LifeFrom pouch
| In the LifeFrom pouch | |
|---|---|
| Product | Resveratrol |
| What one serving holds | Resveratrol Extract (Japanese Knotweed) (Polygonum cuspidatum) (root), 500 mg, yielding 250 mg of trans-resveratrol (Daily Value not established) |
| Form | 1 capsule; vegetarian capsule |
| How it is packed | One serving in each of your 30 daily pouches, with up to 8 supplements per pouch |
| Price | $9.60 a month, plus the fixed $28.50 a month packing, handling and US delivery line for the whole pouch, not per supplement. Prices as of November 2026; the shop shows the current price. |
| Curated packs that include it | Microbiome (with Turmeric, Soothing Fiber Formula, 10B Probiotic, Quercetin and Berberine 300); Antioxidants (with Alpha Lipoic Acid, Trace Minerals, Quercetin, NAC and Vitamin C) |
One capsule's 250 mg of trans-resveratrol is higher than the 150 mg a day used in the 12-month bone trial and matches the 250 mg that blunted training gains in older men. Everything in a pouch is taken at once, so the Microbiome pack puts resveratrol together with berberine and turmeric, and the Antioxidants pack puts it with alpha lipoic acid: anyone on diabetes medicines or a blood thinner should have a pharmacist look at the whole pack, not resveratrol alone. You can see the shop and its packs.
This guide is general education, not medical advice. Supplements are not FDA-approved for safety or effectiveness, and resveratrol's long-term effects at supplement amounts are not well studied. The clinician who knows your history and your medicines is the right person to decide whether resveratrol fits; see our medical disclaimer.
Citations
- Walle T, Hsieh F, DeLegge MH, Oatis JE, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos. 2004;32(12):1377-1382.
- Brown VA, Patel KR, Viskaduraki M, et al. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res. 2010;70(22):9003-9011.
- Gliemann L, Schmidt JF, Olesen J, et al. Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men. J Physiol. 2013;591(20):5047-5059.
- Semba RD, Ferrucci L, Bartali B, et al. Resveratrol levels and all-cause mortality in older community-dwelling adults. JAMA Intern Med. 2014;174(7):1077-1084.
- Zhu X, Wu C, Qiu S, Yuan X, Li L. Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis. Nutr Metab (Lond). 2017;14:60.
- Yoshino J, Conte C, Fontana L, et al. Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance. Cell Metab. 2012;16(5):658-664.
- Timmers S, Konings E, Bilet L, et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 2011;14(5):612-622.
- Chow HH, Garland LL, Hsu CH, et al. Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study. Cancer Prev Res (Phila). 2010;3(9):1168-1175.
- Thaung Zaw JJ, Howe PR, Wong RH. Long-term effects of resveratrol on cognition, cerebrovascular function and cardio-metabolic markers in postmenopausal women: a 24-month randomised, double-blind, placebo-controlled, crossover study. Clin Nutr. 2021;40(3):820-829.
- Thaung Zaw JJ, Howe PRC, Wong RHX. Long-term resveratrol supplementation improves pain perception, menopausal symptoms, and overall well-being in postmenopausal women: findings from a 24-month randomized, controlled, crossover trial. Menopause. 2020;28(1):40-49.
- Wu W, Meng T, Jin F, et al. Effects of resveratrol on postmenopausal women: a systematic review and meta-analysis. Front Pharmacol. 2025;16:1588284.
- Wong RH, Thaung Zaw JJ, Xian CJ, Howe PR. Regular supplementation with resveratrol improves bone mineral density in postmenopausal women: a randomized, placebo-controlled trial. J Bone Miner Res. 2020;35(11):2121-2131.
- Huang TY, Yu CP, Hsieh YW, Lin SP, Hou YC. Resveratrol stereoselectively affected (±)warfarin pharmacokinetics and enhanced the anticoagulation effect. Sci Rep. 2020;10:15910.
- Berman AY, Motechin RA, Wiesenfeld MY, Holz MK. The therapeutic potential of resveratrol: a review of clinical trials. NPJ Precis Oncol. 2017;1:35.
- McDermott MM, Martens CR, Domanchuk KJ, et al. Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial. Nat Commun. 2024;15:5046.
Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.






